{
    "organizations": [],
    "uuid": "3cc6ea692bde119baa30a5d298da19659b374320",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-roche-unit-chugai-says-gets-japane/brief-roche-unit-chugai-says-gets-japanese-approval-of-tecentriq-for-treatment-of-unresectable-advanced-or-recurrent-non-small-cell-lung-cancer-idUSZ8N1GF02G",
    "ord_in_thread": 0,
    "title": "BRIEF-Roche Unit Chugai Says Gets Japanese Approval Of Tecentriq For Treatment Of Unresectable, Advanced Or Recurrent Non-Small Cell Lung Cancer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Roche Holding Ag:\n* ROCHE UNIT CHUGAI SAYS GETS JAPANESE APPROVAL OF TECENTRIQ FOR TREATMENT OF UNRESECTABLE, ADVANCED OR RECURRENT NON-SMALL CELL LUNG CANCER Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-19T14:30:00.000+02:00",
    "crawled": "2018-01-20T17:30:33.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "roche",
        "holding",
        "ag",
        "roche",
        "unit",
        "chugai",
        "say",
        "get",
        "japanese",
        "approval",
        "tecentriq",
        "treatment",
        "unresectable",
        "advanced",
        "recurrent",
        "cell",
        "lung",
        "cancer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}